Neuroendocrine tumors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
ICDO = M8013/3, M8041/3, M8246/3, M8247/3, M8574/3 | | ICDO = M8013/3, M8041/3, M8246/3, M8247/3, M8574/3 | | ||
OMIM = | | OMIM = | | ||
MedlinePlus = | | MedlinePlus = 000393| | ||
eMedicineSubj = | | eMedicineSubj = | | ||
eMedicineTopic = | | eMedicineTopic = | | ||
Revision as of 13:34, 11 September 2012
| Neuroendocrine tumors | |
| ICD-9 | 209 |
|---|---|
| ICD-O: | M8013/3, M8041/3, M8246/3, M8247/3, M8574/3 |
| MedlinePlus | 000393 |
| MeSH | D018358 |
|
Neuroendocrine tumors Microchapters |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Neuroendocrine tumors from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | PET | Endoscopy | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
External links
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.